Log In
BCIQ
Print this Print this
 

RQ-00000774

  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionPotassium competitive acid pump antagonist that inhibits binding of potassium ion to H+/K+ ATPase
Molecular Target H+/K ATPase pump
Mechanism of ActionH+/K+ ATPase pump inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsTreat gastroesophageal reflux disease (GERD)
Regulatory Designation
PartnerCJ Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/06/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today